WALTHAM, MA, UNITED STATES, September 10, 2024 /EINPresswire.com/ — Lionbridge, a global leader in translation and localization solutions, has published a new eBook, “AI and Language Strategy in Life Sciences.” This comprehensive guide explores the transformative impact of artificial intelligence (AI) on language outcomes within the Life Sciences industry. It provides the latest guidance for safely embracing AI to enhance language capabilities across the drug and medical device lifecycle.

Life Sciences companies are adopting AI, but are understandably cautious about trusting Large Language Models (LLMs) and AI to translate regulated content. Lionbridge’s eBook addresses how to achieve trust and control when deploying AI-powered language services. It also offers guidance on where and how LLMs can be utilized for cost efficiency without compromising language quality and compliance.

“As a leader in life sciences language services, Lionbridge is at the forefront of understanding how new language technologies are transforming the industry.”

— Pia Windelov, VP Life Sciences Strategy and Product Marketing

Authored by industry experts Pia Windelov, Vice President of Life Sciences Strategy and Product Marketing at Lionbridge, and Camilla de Villiers, Managing Director of Life Sciences at Lionbridge, the eBook bridges the trust gap and clarifies potential applications of LLMs to produce reliable language outcomes.

Source: https://www.kxan.com/

Full artricle: https://www.kxan.com/business/press-releases/ein-presswire/741986916/lionbridge-publishes-new-ebook-ai-and-language-strategy-in-life-sciences/